vimarsana.com

Page 6 - உலகளாவிய தடுப்பூசி உச்சிமாநாடு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

COVAX ANNOUNCES ADDITIONAL DEALS TO ACCESS PROMISING COVID-19 VACCINE CANDIDATES; PLANS GLOBAL ROLLOUT STARTING Q1 2021

COVAX Announces additional deals to access promising COVID-19 vaccine candidates; plans global rollout starting Q1 2021 COVAX Announces additional deals to access promising COVID-19 vaccine candidates; plans global rollout starting Q1 2021 18 December 2020 Reading time: COVAX now has agreements in place to access nearly two billion doses of several promising vaccine candidates, and laid the groundwork for further doses to be secured through contributions from donors These agreements mean that all COVAX’s 190 participating and eligible economies will be able to access doses to protect vulnerable groups in the first half of 2021. At least 1.3 billion donor-funded doses will be made available to 92 economies eligible for the Gavi COVAX AMC, targeting up to 20% population coverage by the end of the year.

United statesHong kongUnited kingdomNew zealandUniversity of hong kongHong kong generalSouth koreaKarina gouldSeth berkleyNgozi okonjo iwealaWendy mortonJohn nkengasongInge ulsteinRichard hatchettTedros adhanom ghebreyesusPascal soriot

Behind the scenes, the UK is stopping other countries from getting a vaccine — and making Brexit enemies

Behind the scenes, the UK is stopping other countries from getting a vaccine and making Brexit enemies Emin Pasha © Provided by The Independent For Africa s roughly 1.2 billion people, the cost of a coronavirus vaccine ranges from $4 billion (AstraZeneca) to $44 billion (Moderna) not including the cost of developing the infrastructure needed to deliver it. The same applies for India s 1.3 billion people and the other billion in developing countries globally. Without a global vaccination, Covid-19 will remain at large in populations around the world, offering it the opportunity to mutate and surface again. Even while knowing this, the UK and other developed countries are currently working to prevent their developing counterparts from being able to produce the vaccine in an affordable way. Archaic committees and processes within the World Trade Organization are now wrapping up what should be a simple decision for the public good in bureaucracy, putting an i

New yorkUnited statesSouth africaUnited kingdomKaren pierceMario cuomoForeign officeWorld trade organizationPermanent representativeUnited nations karenGlobal vaccine summitTrade related aspectsIntellectual property rightsபுதியது யார்க்ஒன்றுபட்டது மாநிலங்களில்ஒன்றுபட்டது கிஂக்டம்

vimarsana © 2020. All Rights Reserved.